Haynes Boone represented Chembio Diagnostics, Inc. in its public offering of 1,783,760 shares of common stock for $6.75 per share. The offering closed on February 12, 2018.
Representative Matters /
Chembio Diagnostics, Inc. Public Offering
Chembio Diagnostics, Inc. Public Offering of Shares of Common Stock
Participating Lawyers